Page last updated: 2024-08-18

pyrazolanthrone and Leucocythaemia

pyrazolanthrone has been researched along with Leucocythaemia in 15 studies

Research

Studies (15)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (86.67)29.6817
2010's2 (13.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anuchapreeda, S; Chiampanichayakul, S; Krig, SR; Rungrojsakul, M; Tima, S1
Cai, J; Chen, F; Lang, W; Zhong, J; Zhu, J1
Bang, S; Cho, BJ; Cho, D; Hur, D; Kim, CH; Kim, KE; Kim, T; Lee, WJ; Lim, JS; Park, H; Song, H; Yang, Y1
Budhraja, A; Cheng, S; Gao, N; Shi, X; Yao, H; Zhang, Z1
Choi, YH; Kang, CH; Kim, GY; Kim, MO; Lee, JD; Moon, DO1
Abid, K; Aroui, S; Brahim, S; Kenani, A1
An, F; Gajate, C; Mollinedo, F1
Studzinski, GP; Wang, Q; Wang, X1
Dent, P; Grant, S; Rahmani, M; Yu, C1
Chan, R; Chen, D; Jing, Y; Waxman, S1
Chen, GQ; Gao, FH; Li, X; Wang, Q; Wu, YL; Zhao, KW1
Chang, LS; Chen, YL; Chien, CM; Lin, SR; Lu, CM; Yang, SH1
Berger, F; Champelovier, P; El Atifi, M; Pautre, V; Rostaing, B; Seigneurin, D1
Kim, ES; Kim, KE; Kim, KW; Kwon, BC; Shin, MH; Sohn, MH1
Chang, JH; Choi, YH; Kim, GY; Kim, MO; Kim, ND; Moon, DO1

Other Studies

15 other study(ies) available for pyrazolanthrone and Leucocythaemia

ArticleYear
Co-activation of WT1 and AP-1 proteins on WT1 gene promoter to induce WT1 gene expression in K562 cells.
    Cellular signalling, 2019, Volume: 53

    Topics: Abietanes; Anthracenes; Antineoplastic Agents; Curcumin; Gene Expression Regulation, Leukemic; Humans; K562 Cells; Leukemia; Promoter Regions, Genetic; Protein Kinase Inhibitors; Transcription Factor AP-1; WT1 Proteins

2019
EVI-1 modulates arsenic trioxide induced apoptosis through JNK signalling pathway in leukemia cells.
    Experimental cell research, 2019, 01-01, Volume: 374, Issue:1

    Topics: Animals; Anthracenes; Apoptosis; Arsenic Trioxide; Cell Line, Tumor; Disease Models, Animal; Down-Regulation; Gene Expression Regulation, Leukemic; Humans; Leukemia; MAP Kinase Signaling System; MDS1 and EVI1 Complex Locus Protein; Models, Biological; Neoplasm Proteins; RNA, Messenger; Zebrafish

2019
IL-18 enhances ULBP2 expression through the MAPK pathway in leukemia cells.
    Immunology letters, 2008, Oct-30, Volume: 120, Issue:1-2

    Topics: Anthracenes; Cell Line, Tumor; Cytotoxicity, Immunologic; Flavonoids; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Intercellular Signaling Peptides and Proteins; Interleukin-18; Jurkat Cells; Leukemia; Mitogen-Activated Protein Kinases

2008
Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Jan-01, Volume: 15, Issue:1

    Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Grape Seed Extract; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; Plant Extracts; Proanthocyanidins; RNA, Small Interfering; Signal Transduction; Up-Regulation

2009
JNK inhibitor SP600125 promotes the formation of polymerized tubulin, leading to G2/M phase arrest, endoreduplication, and delayed apoptosis.
    Experimental & molecular medicine, 2009, Sep-30, Volume: 41, Issue:9

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Cell Cycle; Enzyme Inhibitors; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia; Tubulin

2009
Involvement of C-jun NH2-terminal kinase and apoptosis induced factor in apoptosis induced by deglycosylated bleomycin in laryngeal carcinoma cells.
    Cell biology international, 2009, Volume: 33, Issue:9

    Topics: Anthracenes; Antibiotics, Antineoplastic; Apoptosis; Apoptosis Inducing Factor; Bleomycin; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Fas Ligand Protein; Humans; JNK Mitogen-Activated Protein Kinases; Laryngeal Neoplasms; Leukemia; Mitochondria; TNF-Related Apoptosis-Inducing Ligand

2009
Rapid and selective apoptosis in human leukemic cells induced by Aplidine through a Fas/CD95- and mitochondrial-mediated mechanism.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Volume: 9, Issue:4

    Topics: Anthracenes; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Carrier Proteins; Caspase 3; Caspases; Cell Line, Tumor; Cells, Cultured; Curcumin; Cytochromes c; Depsipeptides; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Activation; fas Receptor; Flow Cytometry; Glutathione Transferase; Hepatocytes; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; MAP Kinase Kinase 4; Microscopy, Fluorescence; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Peptides, Cyclic; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Time Factors; Tumor Cells, Cultured

2003
Jun N-terminal kinase pathway enhances signaling of monocytic differentiation of human leukemia cells induced by 1,25-dihydroxyvitamin D3.
    Journal of cellular biochemistry, 2003, Aug-15, Volume: 89, Issue:6

    Topics: Anthracenes; Blotting, Western; Cell Differentiation; Dose-Response Relationship, Drug; Electrophoretic Mobility Shift Assay; Enzyme Activation; Enzyme Inhibitors; Ergocalciferols; HL-60 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia; Mitogen-Activated Protein Kinases; Monocytes; Phosphorylation; Proto-Oncogene Proteins c-jun; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factor AP-1; U937 Cells

2003
The hierarchical relationship between MAPK signaling and ROS generation in human leukemia cells undergoing apoptosis in response to the proteasome inhibitor Bortezomib.
    Experimental cell research, 2004, May-01, Volume: 295, Issue:2

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Caspases; Cytochromes c; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; MAP Kinase Signaling System; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Models, Biological; Protease Inhibitors; Pyrazines; Pyridines; Reactive Oxygen Species; Signal Transduction; U937 Cells

2004
Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors.
    Cancer research, 2006, Dec-01, Volume: 66, Issue:23

    Topics: Amino Acid Chloromethyl Ketones; Anthracenes; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Buthionine Sulfoximine; Caspase 3; Caspase Inhibitors; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Glutathione; Humans; Hydrogen Peroxide; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leukemia; Lymphoma; Oxides; Receptors, TNF-Related Apoptosis-Inducing Ligand; Time Factors; U937 Cells

2006
c-Jun N-terminal kinase mediates AML1-ETO protein-induced connexin-43 expression.
    Biochemical and biophysical research communications, 2007, May-04, Volume: 356, Issue:2

    Topics: Anthracenes; Connexin 43; Core Binding Factor Alpha 2 Subunit; DNA-Binding Proteins; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia; Phosphorylation; Promoter Regions, Genetic; Proto-Oncogene Proteins; RUNX1 Translocation Partner 1 Protein; Transcription Factors; Tumor Cells, Cultured

2007
Involvement of c-Jun N-terminal kinase in G2/M arrest and FasL-mediated apoptosis induced by a novel indoloquinoline derivative, IQDMA, in K562 cells.
    Leukemia research, 2007, Volume: 31, Issue:10

    Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspases; Cell Cycle; Cell Division; Cell Line, Tumor; Enzyme Activation; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Fas Ligand Protein; Flow Cytometry; G2 Phase; Humans; Indoles; JNK Mitogen-Activated Protein Kinases; Leukemia; p38 Mitogen-Activated Protein Kinases; Quinolines

2007
Specific inhibition of basal mitogen-activated protein kinases and phosphatidylinositol 3 kinase activities in leukemia cells: a possible therapeutic role for the kinase inhibitors.
    Experimental hematology, 2008, Volume: 36, Issue:1

    Topics: Anthracenes; Apoptosis; Cell Cycle; Cell Cycle Proteins; Cell Differentiation; Cell Division; Cell Line, Tumor; Chromones; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Gene Expression Regulation, Leukemic; HL-60 Cells; Humans; Imidazoles; Leukemia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Monocytes; Morpholines; Neoplasm Proteins; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Pyridines; U937 Cells

2008
House dust mite induces expression of intercellular adhesion molecule-1 in EoL-1 human eosinophilic leukemic cells.
    Journal of Korean medical science, 2007, Volume: 22, Issue:5

    Topics: Animals; Anthracenes; CD11b Antigen; Cell Line, Tumor; Cell Membrane; Eosinophils; Flow Cytometry; Gene Expression Regulation; Humans; Integrin alpha4; Intercellular Adhesion Molecule-1; Leukemia; Leupeptins; Mitogen-Activated Protein Kinase 8; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pyroglyphidae

2007
Bcl-2 overexpression attenuates SP600125-induced apoptosis in human leukemia U937 cells.
    Cancer letters, 2008, Jun-18, Volume: 264, Issue:2

    Topics: Anthracenes; Apoptosis; Blotting, Western; Caspase 3; Cell Cycle; DNA Fragmentation; Enzyme Inhibitors; Flow Cytometry; Humans; JNK Mitogen-Activated Protein Kinases; Leukemia; Proto-Oncogene Proteins c-bcl-2; U937 Cells; Up-Regulation

2008